Leap Therapeutics Inc. (LPTX)
0.42
-0.04 (-9.35%)
At close: Mar 03, 2025, 3:59 PM
0.44
5.04%
After-hours: Mar 03, 2025, 04:59 PM EST
Leap Therapeutics Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Revenue | n/a | n/a | 1.5M | 1.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 427K | 415K | n/a | n/a | 776K | 49K | 48K | 25K | n/a | n/a | n/a | n/a |
| Gross Profit | -427K | -415K | 1.5M | 1.5M | -776K | -49K | -48K | -25K | n/a | n/a | n/a | n/a |
| Operating Income | -87.04M | -56.76M | -41.43M | -28.54M | -33.45M | -30.75M | -32.35M | -27.52M | -21.09M | -20.92M | -13.87M | -8.8M |
| Interest Income | 4.03M | 925K | 9K | 93K | 313K | 447K | 170K | 2K | 156K | 40K | 94K | 102K |
| Pretax Income | -81.41M | -54.45M | -40.61M | -27.52M | -32.9M | -23.12M | -29.88M | -25.63M | -20.95M | -25.42M | -18.18M | -7.76M |
| Net Income | -81.41M | -54.6M | -40.59M | -27.51M | -32.9M | -23.14M | -29.73M | -25.63M | -21.1M | -25.45M | -18.32M | -7.76M |
| Selling & General & Admin | 13.38M | 11.8M | 10.77M | 9.62M | 9.09M | 8.92M | 9.85M | 4.23M | 5.72M | 4.71M | 4.57M | 1.51M |
| Research & Development | 73.23M | 44.97M | 32.16M | 20.42M | 24.37M | 21.07M | 22.5M | 23.29M | 15.37M | 15.54M | 9.3M | 7.17M |
| Other Expenses | n/a | -2.05M | -1.23M | -231K | -132K | 756K | n/a | 3.12M | n/a | n/a | n/a | n/a |
| Operating Expenses | 86.61M | 54.71M | 41.7M | 29.81M | 33.32M | 30M | 32.35M | 27.52M | 21.09M | 20.25M | 13.87M | 8.68M |
| Interest Expense | n/a | 54K | 41K | 39K | 23K | 19K | 121K | 1.23M | 18K | 4.37M | n/a | n/a |
| Selling & Marketing Expenses | -427K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 87.04M | 54.71M | 41.7M | 29.81M | 33.32M | 30M | 32.35M | 27.52M | 21.09M | 20.25M | 13.87M | 8.68M |
| Income Tax | n/a | 147K | -24K | -2K | -3K | 20K | -157K | 4.35M | 152K | 31K | 149K | n/a |
| Shares Outstanding (Basic) | 20.45M | 11.32M | 8.58M | 5.93M | 2.26M | 1.41M | 916.18K | 939.24K | 1.71M | 1.19M | 744.4K | 744.4K |
| Shares Outstanding (Diluted) | 20.45M | 11.32M | 8.58M | 5.93M | 2.26M | 1.44M | 918.86K | 939.24K | 1.71M | 1.19M | 744.4K | 744.4K |
| EPS (Basic) | -3.98 | -4.82 | -4.73 | -4.64 | -14.57 | -16.36 | -32.45 | -27.29 | -12.37 | -21.45 | -24.62 | -10.42 |
| EPS (Diluted) | -3.98 | -4.82 | -4.73 | -4.64 | -14.57 | -16.05 | -32.35 | -27.29 | -12.37 | -21.45 | -24.62 | -10.42 |
| EBITDA | -80.99M | -53.98M | -40.01M | -26.81M | -32.1M | -23.05M | -29.71M | -24.37M | -11.92M | -19.73M | -13.23M | -6.98M |
| Depreciation & Amortization | 427K | 415K | 556K | 668K | 776K | 49K | 48K | 25K | 474K | 657K | 640K | 649K |